ImQuest Life Sciences will become a leader in the
development of exciting new drugs for unmet medical
needs throughout the world.

ImQuest Life Sciences Directors

Daniel R. Caffoe - Co-Founder and Chairman of the Board

Robert W. Buckheit - Co-Founder, Executive Vice President and CSO

Dan Williams, JD, LLM - Vice President of Tax and Chief Financial Officer

Dan Beihl - MD, Medical Director

Other Links

Meet the Management

Advisory Board

About Us

ImQuest Life Sciences is currently focusing on the following drug development programs, through the formation of alliances and partnerships as well as through exclusive world wide licensing:

Therapies for the treatment of HIV

Topical microbicides for the prevention of transmission of HIV and other sexually transmitted infections

Therapies for the treatment of HBV and HCV

Therapies for the treatment of cancer